PSA advocates to support the future development of our profession, as well as promoting work pharmacists do so that it’s understood by Governments, stakeholders, healthcare professionals and the public. Read more about our current priorities.
PSA has resources and tools to assist you build your Career and annual CPD plan so you can maintain registration and learn with purpose. No matter what pathway or stage of practice you are in - or where you want to go, PSA can help.
PSA practice support resources ensure pharmacists can deliver excellence in the practice of pharmacy. Pharmacists will find information, guidance and practice tools on a wide range of topics including standards, guidelines, law and ethics, APF, our policies and much more.
As the peak national health body for pharmacists, PSA offers you a range of opportunities to connect and engage with other pharmacists and industry leaders. These include events and conferences, special interest groups and social media.
PSA is committed to developing capability within the pharmacy profession by supporting both individuals and businesses to make the most of future opportunities. Read more about these innovative programs.
PSA's has recommended the Federal Government consider implementing a large-scale trial to integrate pharmacists in general practice and developing a pharmacist-delivered Minor Ailments Service (MAS) in community pharmacies as part of the 2018-19 Budget.
The Review of Pharmacy Remuneration and Regulation presents an opportunity to explore innovative and sustainable ways pharmacists can contribute to Australia’s health system and optimise healthcare into the future.
The purpose of this paper is to outline the views of the Pharmaceutical Society of Australia (PSA) with respect to the current regulatory environment underpinning the community pharmacy sector in Australia.
PSA is urging all political parties to consider a number of key health policies on the run-up to the 2013 Federal Election. Chronic disease and our ageing population are placing increasing demands on our health system.
PSA lodged its 2016-17 Federal Budget submission on February 5, highlighting key areas where existing health resources can be better coordinated and targeted within a collaborative primary health care model to improve outcomes for all Australians.
In its 2014-15 Federal Budget submission, PSA has proposed a workforce program to help close the Indigenous health gap, increased use of clinical pharmacists in rural and remote areas, and a better response to diabetes through coordination of care.
PSA has provided a brief submission to the Senate Community Affairs Committee Inquiry into the Supply of Chemotherapy Drugs such as Docetaxel.
PSA’s submission addresses two issues regarding the supply of chemotherapy drugs in both private and public hospitals: the cost of medicine to the pharmacy; and the cost of dispensing medicines to the patient.
PSA has provided a submission to the Treasury on the Government’s proposal to introduce a $2,000 cap on deductions for work-related educational expenses. PSA regards this as a highly discriminatory measure that will adversely impact Australia’s pharmacists.
The Society said in a submission to the Senate Community Affairs References Committee that a program of clinical interventions by pharmacists should be included in the Fifth Community Pharmacy Agreement.
The PSA told the Senate Finance and Public Administration References Committee that delays by the Australian Health Practitioner Regulation Agency in registering pharmacists and intern pharmacists have caused unnecessary financial burdens and stress.